Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
12201
CALL
PetMed Express
PETS
$28.4M
| $57.4K | ﹤0.01% |
11,900
+3,200
| +37% | +$15K |
2017 Q2
30 quarters
|
|
12202
CALL
Stock Yards Bancorp
SYBT
$2.39B
| $57.3K | ﹤0.01% |
800
-1,300
| -62% | -$91.6K |
2023 Q3
5 quarters
|
|
12203
Minerva Neurosciences
NERV
$164M
| $57.2K | ﹤0.01% |
25,764
+8,525
| +49% | +$20.1K |
2024 Q3
1 quarter
|
|
12204
CALL
First Trust North American Energy Infrastructure Fund
EMLP
$4.05B
| $57K | ﹤0.01% |
1,600
+1,400
| +700% | +$49.6K |
2023 Q1
7 quarters
|
|
12205
PUT
Evolution Petroleum
EPM
$146M
| $57K | ﹤0.01% |
10,900
+6,700
| +160% | +$36.7K |
2020 Q3
17 quarters
|
|
12206
CALL
CION Investment
CION
$342M
| $57K | ﹤0.01% |
+5,000
| New | +$58.3K |
2024 Q4
0 quarters
|
|
12207
CALL
Actinium Pharmaceuticals
ATNM
$34.9M
| $57K | ﹤0.01% |
45,200
-20,000
| -31% | -$31K |
2020 Q4
16 quarters
|
|
12208
PUT
Amalgamated Financial
AMAL
$1.42B
| $56.9K | ﹤0.01% |
1,700
+1,100
| +183% | +$37.8K |
2024 Q3
1 quarter
|
|
12209
CALL
Gorman-Rupp
GRC
$2.04B
| $56.9K | ﹤0.01% |
1,500
-1,700
| -53% | -$67.9K |
2022 Q4
8 quarters
|
|
|
VNET
12210
PUT
VNET Group
VNET
$1.54B
| $56.9K | ﹤0.01% |
12,000
-4,200
| -26% | -$16K |
2023 Q2
6 quarters
|
|
12211
PUT
PepGen
PEPG
$160M
| $56.9K | ﹤0.01% |
+15,000
| New | +$93.5K |
2024 Q4
0 quarters
|
|
|
CDMO
12212
PUT
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $56.8K | ﹤0.01% |
4,600
-103,600
| -96% | -$1.19M |
2022 Q4
8 quarters
|
|
12213
Black Stone Minerals
BSM
$3.12B
| $56.8K | ﹤0.01% |
3,890
-96,739
| -96% | -$1.44M |
2023 Q3
5 quarters
|
|
|
SMC
12214
PUT
Summit Midstream
SMC
$457M
| $56.7K | ﹤0.01% |
1,500
-1,900
| -56% | -$68.3K |
2024 Q1
3 quarters
|
|
12215
PUT
Southwest Gas
SWX
$6.04B
| $56.6K | ﹤0.01% |
800
-900
| -53% | -$66.9K |
2021 Q1
15 quarters
|
|
12216
DarioHealth
DRIO
$59M
| $56.5K | ﹤0.01% |
3,597
+279
| +8% | +$4.83K |
2024 Q2
2 quarters
|
|
12217
CALL
Business First Bancshares
BFST
$1B
| $56.5K | ﹤0.01% |
2,200
-200
| -8% | -$5.37K |
2023 Q3
5 quarters
|
|
12218
PUT
TFS Financial
TFSL
$4.65B
| $56.5K | ﹤0.01% |
4,500
-7,500
| -63% | -$99.8K |
2021 Q2
14 quarters
|
|
12219
CALL
Caledonia Mining Corp
CMCL
$480M
| $56.5K | ﹤0.01% |
6,000
+1,200
| +25% | +$15.3K |
2022 Q4
8 quarters
|
|
|
IPM
12220
Intelligent Protection Management Corp
IPM
$23.2M
| $56.5K | ﹤0.01% |
+28,368
| New | +$59.2K |
2024 Q4
0 quarters
|
|
|
FPI
12221
PUT
Farmland Partners
FPI
$469M
| $56.4K | ﹤0.01% |
4,800
-26,400
| -85% | -$310K |
2020 Q3
17 quarters
|
|
|
CRSH
12222
PUT
YieldMax Short TSLA Option Income Strategy ETF
CRSH
$13.6M
| $56.4K | ﹤0.01% |
+920
| New | +$86.8K |
2024 Q4
0 quarters
|
|
12223
CALL
IZEA Worldwide
IZEA
$42.7M
| $56.4K | ﹤0.01% |
+20,500
| New | +$55K |
2024 Q4
0 quarters
|
|
12224
PUT
Franklin Covey
FC
$197M
| $56.4K | ﹤0.01% |
1,500
+800
| +114% | +$30.7K |
2024 Q1
3 quarters
|
|
12225
CALL
Central Garden & Pet Co Class A
CENTA
$2.17B
| $56.2K | ﹤0.01% |
+1,700
| New | +$54.1K |
2024 Q4
0 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.